Cargando…
Epigenetic Control of Gene Expression in the Normal and Malignant Human Prostate: A Rapid Response Which Promotes Therapeutic Resistance
A successful prostate cancer must be capable of changing its phenotype in response to a variety of microenvironmental influences, such as adaptation to treatment or successful proliferation at a particular metastatic site. New cell phenotypes emerge by selection from the large, genotypically heterog...
Autores principales: | Frame, Fiona M., Maitland, Norman J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566891/ https://www.ncbi.nlm.nih.gov/pubmed/31108832 http://dx.doi.org/10.3390/ijms20102437 |
Ejemplares similares
-
Low Temperature Plasma: A Novel Focal Therapy for Localized Prostate Cancer?
por: Hirst, Adam M., et al.
Publicado: (2014) -
Low temperature plasmas as emerging cancer therapeutics: the state of play and thoughts for the future
por: Hirst, Adam M., et al.
Publicado: (2016) -
Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies
por: Tao, Fangfang, et al.
Publicado: (2023) -
ETS transcription factor ELF3 (ESE‐1) is a cell cycle regulator in benign and malignant prostate
por: Archer, Leanne K., et al.
Publicado: (2022) -
Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target
por: Quattrini, Luca, et al.
Publicado: (2020)